| PTLO |
Michael A Miles Jr |
Chair/Int. CEO |
10/15/25 |
Award |
0 |
199,005 |
1,200,001 |
245,413 |
| RBRK |
Kiran Kumar Choudary |
CFO |
10/15/25 |
Sell |
79.78 |
1,500 |
119,673 |
512,051 |
| NRDY |
John Andrew Paszterko |
COO |
10/15/25 |
Award |
0 |
600,000 |
666,000 |
600,000 |
| BEN |
Daniel Gamba |
Co-Pres. |
10/15/25 |
Award |
0 |
442,870 |
10,093,007 |
442,870 |
| EA |
Vijayanthimala Singh |
Chf People Off |
10/15/25 |
Sell |
200.31 |
1,200 |
240,372 |
32,331 |
| SNX |
Patrick Zammit |
CEO |
10/15/25 |
Award |
0 |
22,957 |
3,599,887 |
182,292 |
| EA |
Jacob J Schatz |
CLO |
10/15/25 |
Sell |
200.8 |
1,200 |
240,962 |
24,880 |
| NWN |
David Hugo Anderson |
N/A |
10/15/25 |
Sell |
45 |
10,509 |
472,913 |
62,427 |
| GTLB |
Sytse Sijbrandij |
Chair |
10/15/25 |
Sell |
44.29 |
108,600 |
4,809,873 |
0 |
| ROKU |
Dan Jedda |
CFO & COO |
10/15/25 |
Sell |
95.82 |
3,000 |
287,460 |
80,420 |
| GRAL |
William Chase |
N/A |
10/15/25 |
Award |
0 |
275 |
20,769 |
36,590 |
| GRAL |
Gregory L Summe |
Chair |
10/15/25 |
Award |
0 |
425 |
32,097 |
38,794 |
| GRAL |
Steven C Mizell |
N/A |
10/15/25 |
Award |
0 |
267 |
20,163 |
36,469 |
| GTLB |
Karen Blasing |
N/A |
10/15/25 |
Sell |
45.26 |
3,250 |
147,095 |
97,389 |
| RMI |
American Shareholder |
N/A |
10/15/25 |
Buy |
14.74 |
4,138 |
60,993 |
6,281 |
| TEAM |
Scott Farquhar |
N/A |
10/15/25 |
Sell |
151.83 |
7,665 |
1,163,775 |
406,245 |
| TEAM |
Michael Cannon-Brookes |
CEO |
10/15/25 |
Sell |
151.83 |
7,665 |
1,163,773 |
406,245 |
| REFI |
Dr Jason D Papastavrou |
Lead Indpdt. Dir |
10/15/25 |
Buy |
12.65 |
18,000 |
227,740 |
57,546 |
| ATI |
Kimberly A Fields |
CEO |
10/15/25 |
Sell |
85.87 |
21,153 |
1,816,408 |
202,668 |
| EQH |
Jeffrey J Hurd |
COO |
10/15/25 |
Sell |
48.99 |
6,790 |
332,632 |
75,098 |
| REFI |
David Kite |
COO |
10/15/25 |
Buy |
12.51 |
5,000 |
62,526 |
59,516 |
| PLUR |
Yaky Yanay |
CEO |
10/15/25 |
Award |
0 |
39,050 |
175,979 |
492,006 |
| GSAT |
Rebecca S Clary |
CFO |
10/15/25 |
Award |
0 |
9,524 |
424,485 |
115,185 |
| PNTG |
Stephen M R Covey |
N/A |
10/15/25 |
Award |
0 |
1,900 |
46,056 |
38,350 |
| PNTG |
Suzanne D Snapper |
N/A |
10/15/25 |
Award |
0 |
1,900 |
46,056 |
224,664 |
| PNTG |
Barry M Smith |
Chair |
10/15/25 |
Award |
0 |
1,900 |
46,056 |
96,799 |
| PNTG |
Scott E Lamb |
N/A |
10/15/25 |
Award |
0 |
2,400 |
58,176 |
51,735 |
| PNTG |
Dr John G Nackel |
N/A |
10/15/25 |
Award |
0 |
1,900 |
46,056 |
171,565 |
| PNTG |
Christopher R Christensen |
N/A |
10/15/25 |
Award |
0 |
1,900 |
46,056 |
763,638 |
| PNTG |
Gregory K Morris |
N/A |
10/15/25 |
Award |
0 |
1,900 |
46,056 |
31,600 |
| PCOR |
Kevin J O Connor |
N/A |
10/15/25 |
Sell |
71.54 |
15,384 |
1,100,532 |
1,124,577 |
| CMP |
Edward C Dowling |
CEO |
10/15/25 |
Award |
0 |
45,467 |
887,970 |
55,671 |
| ZS |
Adam Geller |
CPO |
10/15/25 |
Award |
0 |
10,730 |
3,244,215 |
54,208 |
| ZS |
Robert Schlossman |
CLO |
10/15/25 |
Award |
0 |
7,154 |
2,163,012 |
83,352 |
| BCAX |
Ryan Cohlhepp |
COO |
10/15/25 |
Sell |
18.16 |
4,500 |
81,699 |
198,141 |
| COCO |
Kenneth Sadowsky |
N/A |
10/15/25 |
Sell |
38.92 |
3,900 |
151,769 |
619,966 |
| CMPR |
Florian Baumgartner |
EVP |
10/15/25 |
Award |
0 |
1,025 |
66,395 |
56,431 |
| ZS |
Michael J Rich |
Chf Revenue Of |
10/15/25 |
Award |
0 |
10,730 |
3,244,215 |
111,552 |
| KPTI |
Kristin Abate |
CAO |
10/15/25 |
Award |
0 |
12,799 |
76,154 |
22,845 |
| MCO |
Robert Fauber |
CEO |
10/15/25 |
Sell |
481.09 |
134 |
64,466 |
61,082 |
| QCOM |
Baaziz Achour |
CTO |
10/15/25 |
Award |
0 |
721 |
117,502 |
86,460 |
| QCOM |
Cristiano R Amon |
CEO |
10/15/25 |
Award |
0 |
1,940 |
316,161 |
158,688 |
| RAPP |
Abraham Ceesay |
CEO |
10/15/25 |
Sell |
25.81 |
10,916 |
281,729 |
702,369 |
| BKNG |
Glenn D Fogel |
CEO |
10/15/25 |
Sell |
5184.62 |
1,013 |
5,252,021 |
22,594 |
| GDRX |
American Shareholder |
N/A |
10/15/25 |
Sell |
4 |
23,771 |
95,103 |
0 |
| TRAK |
Randall K. Fields |
Chair & CEO |
10/15/25 |
Sell |
14.49 |
7,500 |
108,643 |
4,706,025 |
| QCOM |
Alexander H Rogers |
Div. Pres. |
10/15/25 |
Award |
0 |
590 |
96,152 |
24,303 |
| SGA |
American Shareholder |
N/A |
10/15/25 |
Sell |
12.53 |
1,430 |
17,921 |
889,139 |
| BKNG |
Vanessa A Wittman |
N/A |
10/15/25 |
Sell |
5291.98 |
15 |
79,380 |
732 |
| RAPP |
David Bredt |
CSO |
10/15/25 |
Sell |
25.79 |
8,500 |
219,197 |
409,642 |
| KPTI |
Michael Mano |
Gen Cou |
10/15/25 |
Award |
0 |
43,650 |
259,717 |
65,075 |
| DRS |
John Baylouny |
COO |
10/15/25 |
Sell |
43.69 |
8,481 |
370,535 |
106,007 |
| V |
William (Bill) J Ready |
N/A |
10/15/25 |
Award |
0 |
251 |
86,768 |
251 |
| KPTI |
Lori A Macomber |
CFO & Treas |
10/15/25 |
Award |
0 |
43,650 |
259,717 |
54,316 |
| KPTI |
Sohanya Roshan Cheng |
Chf Com Off. |
10/15/25 |
Award |
0 |
43,650 |
259,717 |
79,506 |
| KPTI |
Richard A Paulson |
CEO |
10/15/25 |
Award |
0 |
114,285 |
679,995 |
198,331 |
| KPTI |
Stuart Poulton |
CDO |
10/15/25 |
Award |
0 |
39,682 |
236,108 |
67,392 |
| KVYO |
Stephen (Steve) Eric Rowland |
Pres. |
10/15/25 |
Sell |
24.35 |
7,105 |
173,007 |
431,516 |
| SATL |
Emiliano Kargieman |
CEO |
10/15/25 |
Sell |
4.07 |
294,161 |
1,198,000 |
1,323,482 |
| ARLO |
Kurtis Joseph Binder |
CFO & COO |
10/15/25 |
Sell |
17.82 |
51,668 |
920,527 |
416,013 |
| SCVL |
Andrea R Guthrie |
N/A |
10/15/25 |
Sell |
20.21 |
2,477 |
50,047 |
24,405 |
| CSAI |
Sheldon Richard Bentley |
N/A |
10/15/25 |
Sell |
1.35 |
50,000 |
67,500 |
50,000 |
| ASA |
American Shareholder |
N/A |
10/15/25 |
Buy |
50.51 |
45,003 |
2,272,990 |
4,847,405 |
| ECAT |
American Shareholder |
N/A |
10/15/25 |
Sell |
16.5 |
57,169 |
943,322 |
27,561,089 |
| VANI |
Gregg Williams |
Chair |
10/15/25 |
Buy |
1.14 |
1,737,764 |
1,983,310 |
22,446,312 |
| WAB |
Rafael Santana |
CEO |
10/15/25 |
Sell |
196.14 |
3,596 |
705,331 |
131,335 |
| STRO |
Kwok Lee (Gregory) Chow |
CFO & PAO |
10/15/25 |
Buy |
0.81 |
19,750 |
15,998 |
19,750 |
| STRO |
Hans-Peter Gerber |
CSO |
10/15/25 |
Buy |
0.8 |
17,000 |
13,607 |
71,832 |
| STRO |
Connie L Matsui |
Chair |
10/15/25 |
Buy |
0.8 |
50,000 |
39,950 |
50,000 |
| STRO |
Jane Chung |
CEO |
10/15/25 |
Buy |
0.8 |
12,500 |
10,011 |
122,850 |
| CYBR |
Richard Turner |
Div. Pres. |
10/15/25 |
Award |
0 |
1,375 |
672,252 |
N/A |
| CD |
Wilfred Zhongkei Daye |
CSO |
10/15/25 |
Sell |
15.64 |
41,665 |
651,641 |
N/A |
| CYBR |
Mary Yang |
N/A |
10/15/25 |
Award |
0 |
65 |
31,779 |
N/A |
| GLBE |
Nir Debbi |
Pres. |
10/15/25 |
Sell |
33.76 |
20,830 |
703,220 |
N/A |
| FSM |
Cesar Velasco |
N/A |
10/15/25 |
Sell |
9.75 |
50,000 |
487,620 |
94,434 |
| BYSI |
American Shareholder |
N/A |
10/15/25 |
Sell |
1.68 |
153,816 |
259,165 |
4,159,347 |
| VRSK |
Elizabeth D Mann |
CFO |
10/15/25 |
Sell |
242.23 |
300 |
72,669 |
14,865 |
| ACLX |
Michelle Gilson |
CFO |
10/15/25 |
Sell |
91.04 |
5,364 |
488,316 |
8,466 |
| SERA |
Tiffany Eul Davis Inglis |
Chf Med Off. |
10/15/25 |
Award |
0 |
75,000 |
236,250 |
75,000 |
| SG |
Jamie Mcconnell |
CFO & PAO |
10/15/25 |
Award |
0 |
150,000 |
1,153,499 |
150,000 |
| MLYS |
Dr David Malcom Rodman |
Chf Med Off. |
10/15/25 |
Sell |
43.01 |
10,369 |
445,983 |
71,155 |
| SION |
Dr Bruce Booth |
N/A |
10/15/25 |
Sell |
30.47 |
194,932 |
5,939,774 |
3,370,849 |
| ALKS |
Craig C Hopkinson |
Chf Med Off. |
10/15/25 |
Sell |
31.53 |
4,000 |
126,122 |
73,740 |
| PATH |
Brad Brubaker |
Gen Cou |
10/15/25 |
Sell |
16.68 |
27,580 |
459,926 |
662,939 |
| TBRG |
Michael Daughton |
CBO |
10/15/25 |
Award |
0 |
7,492 |
150,214 |
7,492 |
| PATH |
Daniel Dines |
Chair & CEO |
10/15/25 |
Sell |
16.92 |
122,734 |
2,077,212 |
30,281,319 |
| PATH |
Hitesh Ramani |
CAO |
10/15/25 |
Sell |
16.61 |
20,000 |
332,152 |
232,776 |
| IPGP |
American Shareholder |
N/A |
10/15/25 |
Sell |
83.64 |
66,500 |
5,562,140 |
6,992,599 |
| NVDA |
Dr Jen Hsun (Jensen) Huang |
CEO |
10/15/25 |
Sell |
183.73 |
225,000 |
41,338,552 |
852,583,603 |
| ETD |
M Farooq Kathwari |
Chair & CEO |
10/15/25 |
Sell |
28.01 |
15,700 |
439,757 |
1,697,768 |
| KYMR |
Jared Gollob |
Chf Med Off. |
10/15/25 |
Sell |
61.42 |
8,367 |
513,915 |
109,992 |
| GEVO |
Christopher Michael Ryan |
COO |
10/15/25 |
Sell |
2.82 |
100,000 |
281,870 |
1,553,946 |
| PB |
Ned S Holmes |
N/A |
10/15/25 |
Sell |
65.27 |
1,100 |
71,794 |
327,318 |
| FCFS |
R Douglas Orr |
CFO |
10/15/25 |
Sell |
159.61 |
7,500 |
1,197,100 |
179,411 |
| YELP |
David A Schwarzbach |
CFO |
10/15/25 |
Sell |
33.58 |
10,000 |
335,786 |
160,196 |
| RGP |
Kate W Duchene |
CEO & COO |
10/15/25 |
Buy |
4.36 |
23,015 |
100,451 |
590,234 |
| KROS |
American Shareholder |
N/A |
10/15/25 |
Sell |
17.75 |
5,389,264 |
95,659,437 |
0 |
| FAT |
American Shareholder |
N/A |
10/14/25 |
Sell |
2 |
53,313 |
106,625 |
1,934,732 |
| GRX |
Anthonie C Vanekris |
N/A |
10/14/25 |
Sell |
9.2 |
4,000 |
36,807 |
2,185 |
| FCNCP |
Richard Blumenthal |
US Senator |
10/14/25 |
Sell |
0 |
1 |
75,000 |
N/A |